Bristol Myers Squibb Drugs - Search News

schizophrenia, Bristol Myers Squibb

Hosted on MSN · 2d

Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the latter part of the year.

NBC Washington · 4d

Bristol Myers Squibb CEO describes new drug for treating schizophrenia

Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar disorder and Alzheimer’s disease.

Bristol Myers Says New Schizophrenia Drug Off to Strong Start

Bristol Myers Squibb Co. said its new schizophrenia drug is off to a better start than similar recently launched treatments, in an early sign that its $14 billion purchase of Karuna Therapeutics is paying off.

Business Insider · 3d

Bristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reports

Bristol Myers (BMY) new psychiatric drug Cobenfy is effective in treating schizophrenia without “the serious side effects’ of other older

Ozempic Among Next Drugs Up for Medicare Price Negotiations

The Hill on MSN · 11h

The next 15 drugs chosen for Medicare negotiation

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on efforts to reduce prescription drug costs.

FOX News on MSN · 10h

Ozempic, Wegovy among drugs subject to Medicare price controls

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.

FiercePharma13h

Novo's semaglutide among 2nd batch of drugs selected for IRA price negotiations

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Benefits Pro11h

Ozempic among 15 drugs selected for Medicare drug price talks, Round 2, with Big Pharma

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

2d

AbbVie CEO says psychiatric drug space challenging, more cautious on investments

AbbVie will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an ...

FDA approves first new schizophrenia drug in more than 30 years

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

4d

ArsenalBios Says Bristol Myers Squibb Exercises Exclusive License Option For AB-4000 Series Programs

Arsenal Biosciences, Inc., a clinical-stage programmable cell therapy company, announced Monday that drug maker Bristol-Myers Squibb ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results